Park Medi World IPO Analyzed

The initial public offering (IPO) for Park Medi World, a major hospital chain in India, has generated significant investor interest. As of Wednesday, December 10th, 2025, the IPO received bids for 219,00,048 shares, compared to the initial offer of 418,18,182 shares. This indicates a relatively subdued demand, with the IPO being subscribed just 0.52 times. Understanding these numbers is crucial for investors considering this opportunity.

Key Points

• IPO subscribed 0.52 times – low investor demand observed.
• Bids received for 219 million shares against 418 million offered.
• IPO price band: Rs 154 to Rs 162 per share.
• Minimum bid: 92 equity shares, multiples thereof.
• Funds raised from anchor investors: Rs 275.99 crore.
• Park Medi World: Large hospital chain with 3,250 beds.

The IPO’s price range is between Rs 154 and Rs 162 per share. Investors can bid for a minimum of 92 equity shares, and the bids must be in whole numbers. This pricing structure provides a range of options depending on an investor’s risk tolerance and investment goals.

Park Medi World is aiming to raise up to Rs 770 crore through this IPO, with Rs 150 crore offered for sale by existing shareholders. The funds raised will be used strategically – Rs 380 crore for debt repayment, Rs 60.5 crore for a new hospital project, and Rs 27.45 crore for medical equipment. The remaining funds will be allocated to acquisitions and general corporate purposes.

The promoters, Dr. Ajit Gupta and Dr. Ankit Gupta, hold a significant stake in the company, controlling approximately 95.55% of the shares before the IPO. This strong promoter presence provides stability and confidence for investors.

Park Medi World operates a large network of hospitals, currently boasting 3,250 beds across 14 NABH-accredited facilities in Haryana. They are actively expanding with new hospitals planned in various locations, aiming to significantly increase their total bed capacity to 4,900 by FY28. This expansion strategy demonstrates the company’s growth potential.

Recent news indicates that Park Medi World raised an additional Rs 275.99 crore from anchor investors prior to the IPO. This pre-IPO funding further validates the company’s prospects and demonstrates confidence from institutional investors.

The company’s financial performance is strong, reporting a consolidated net profit of Rs 139.14 crore and an income from operations of Rs 808.66 crore for the nine months ended June 30, 2025. These figures indicate a healthy and growing business.

Ultimately, this IPO represents a significant opportunity to invest in a growing healthcare giant.